Save the Children and GSK joined forces in 2013, combining our global expertise, skills and energy to help save one million children’s lives by reducing preventable deaths of children under 5. •The partnership supports programme work in 41 countries. We have two multi-million-pound flagship programmes, in the Democratic Republic of Congo (DRC) and Kenya, tackling severe challenges in the supply of and demand for effective healthcare for mothers and their babies. •From September 2016 to August 2017 14,738 children in Kenya and 39,537 children in the DRC were reached though lifesaving interventions of the partnership. •The advocacy efforts of the programme in Kenya have contributed to a 7% increase in the Bungoma county health budget. •The partnership has developed a gel, which is a reformulation of chlorhexidine, for the prevention of umbilical cord infections that can lead to potentially life-threatening neonatal sepsis. To date over 18,000 newborns in Kenya have benefited from the new chlorhexidine gel. •The partnership’s united voice been used successfully to advocate for improved access to healthcare. In 2017 the partnership hosted a conference with the International Federation of Pharmaceutical Manufacturers and Associations to discuss how we can increase access to medicines for low- and middle-income countries.